NNFA opens D.C. office
This article was originally published in The Tan Sheet
Executive Summary
Trade group's Washington, D.C. office opened April 30 to "expand advocacy efforts with federal legislators and regulators on behalf of its members and the natural products industry." NNFA Executive Director & CEO David Seckman is first to relocate to the new office, "which will initially deal primarily with government relations and public affairs," group says. NNFA, which has been planning the move for more than a year, will evaluate its staffing needs as time goes on; group retains its Newport Beach, Calif. office. D.C. branch is located at 1220 19th St. NW, Suite 400...
You may also be interested in...
Mr. Seckman goes to Washington
NNFA Executive Director & CEO David Seckman's lobbying efforts have targeted members of House Energy & Commerce Committee, which is investigating supplements including ephedra and andro. NNFA reports Seckman visited more than 30 Congressional offices in his first week in Washington, D.C. to educate members, staff on DSHEA and to promote message that FDA has sufficient authority to regulate supplements. Seckman also met with FDA Deputy Commissioner Lester Crawford, PhD, and others May 23 to discuss andro and other issues, such as FDA's authority under DSHEA. NNFA opened Washington office in April (1"The Tan Sheet" May 5, 2003, In Brief)...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.